Metabolic deregulation is central to the etiology of prostatic cancer [39]; overexpression of c-Myc in tumors has a profound impact on cell metabolism because it induces a global metabolic reprograming that supports cancer cell survival and growth [40]. The gene discussed is MYC; the disease is prostate carcinoma.